Last reviewed · How we verify
NCT03955432: LOOP
Long-term Cardiac Monitoring in Epilepsy
NA trial testing Reveal LINQ ICM System in Focal Epilepsy in 7 participants. Terminated before completion.
1 November 2022
Quick facts
| Lead sponsor | Northwell Health |
|---|---|
| Phase | NA |
| Status | Terminated |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 7 |
| Start date | 19 March 2019 |
| Primary completion | 1 November 2022 |
| Estimated completion | 3 January 2023 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Reveal LINQ ICM System
Conditions studied
- Focal Epilepsy — all drugs for Focal Epilepsy →
- Intractable Epilepsy — all drugs for Intractable Epilepsy →
- Epileptic Encephalopathy — all drugs for Epileptic Encephalopathy →
- Lennox Gastaut Syndrome — all drugs for Lennox Gastaut Syndrome →
Sponsor
Northwell Health — full company profile →
Who can join
Adults 18 to 50, any sex, with Focal Epilepsy or Intractable Epilepsy. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The purpose of this research study to investigate, classify, and quantify chronic cardiac rhythm disorders in three groups of patients with epilepsy (intractable focal epilepsy, controlled focal epilepsy and symptomatic generalized epilepsy). Patients with epilepsy have a higher risk for cardiac complications than the general population. With this study, we aim to understand more about these potential complications in patients with epilepsy and assess if treatments for cardiac problems should be evaluated more carefully in patients with epilepsy.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT03955432
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Focal Epilepsy
Currently open trials in the same condition.
- NCT07219407 — A Long-term Study of the Safety and Effectiveness of RAP-219 in Adults With Focal Onset Seizures · Phase 2 · recruiting
- NCT07193277 — Butylphthalide for Cognitive Impairment in Elderly Patients With Focal Epilepsy · Phase 4 · recruiting
- NCT07139457 — Wearable Epileptic Seizure Prediction and Alert Glasses Based on Neuromorphic Computing · NA · active not recruiting
- NCT06210022 — Cognitive Impairment in Drug-resistant and Drug-responsive Focal Cryptogenic Epilepsy · recruiting
- NCT05981755 — Breathing Rescue for SUDEP Prevention · NA · recruiting
Other Northwell Health trials
Trials by the same sponsor.
- NCT07253662 — Pressurized Intraperitoneal Aerosolized Chemotherapy (PIPAC) in Patients With Peritoneal Metastasis From Pancreatic Aden · Phase 1 · recruiting
- NCT07191041 — Emotional Urinary Tract Infection · not yet recruiting
- NCT07254091 — Pilot Study of an Implantable Microdevice for In Situ Evaluation of Drug Response in Patients With Pancreatic Cancer · EARLY_PHASE1 · recruiting
- NCT07344961 — Determinates of Atrial Tracking and Prevalence of Atrial Fibrillation in the Micra AV2 (DANCE AFIB) · recruiting
- NCT07193862 — Pilot Study of an Implantable Microdevice for In Situ Evaluation of Drug Response in Patients With Colorectal Liver Meta · EARLY_PHASE1 · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03955432 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Northwell Health
- Last refreshed: 8 February 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03955432.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing